{"id":"cbt-001-single-dose","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL4303484","moleculeType":"Small molecule","molecularWeight":"548.64"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CBT-001 works by blocking the interaction between CD47 and SIRPα on the surface of immune cells, thereby enhancing phagocytosis of tumor cells. This mechanism is thought to be involved in the anti-tumor activity of CBT-001.","oneSentence":"CBT-001 is a small molecule that targets the CD47/SIRPα axis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:49:45.491Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic solid tumors"}]},"trialDetails":[{"nctId":"NCT03049852","phase":"PHASE2","title":"Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium","status":"COMPLETED","sponsor":"Cloudbreak Therapeutics, LLC","startDate":"2017-04-15","conditions":"Pterygium","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CBT-001 single dose","genericName":"CBT-001 single dose","companyName":"Cloudbreak Therapeutics, LLC","companyId":"cloudbreak-therapeutics-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CBT-001 is a small molecule that targets the CD47/SIRPα axis. Used for Metastatic solid tumors.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}